ArticleNeoplasia (New York, N.Y.)2009

Development of a fully human anti-PDGFRbeta antibody that suppresses growth of human tumor xenografts and enhances antitumor activity of an anti-VEGFR2 antibody.

Juqun Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.